Myosteatosis as a prognostic factor of Mycobacterium avium complex pulmonary disease

Myosteatosis as a prognostic factor of Mycobacterium avium complex pulmonary disease

Abstract Quantitative body composition affects the prognosis of patients with Mycobacterium avium complex pulmonary disease (MAC-PD). However, whether the qualitative body composition obtained indirectly through computed tomography (CT) affects their prognosis is debatable. We retrospectively analyz...

Full description

Bibliographic Details
Main Authors:	Eunki Chung, Youngmok Park, Song Yee Kim, Moo Suk Park, Young Sam Kim, Hye-Jeong Lee, Young Ae Kang
Format:	Article
Language:	English
Published:	Nature Portfolio 2023-08-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-023-40984-y

Similar Items

Impact of prognostic nutritional index on outcomes in patients with Mycobacterium avium complex pulmonary disease.
by: Sung Woo Moon, et al.
Published: (2020-01-01)

Clinical characteristics and treatment outcomes of patients with macrolide-resistant Mycobacterium avium complex pulmonary disease: a systematic review and meta-analysis
by: Youngmok Park, et al.
Published: (2019-12-01)

Prognostic Impact of Myosteatosis on Mortality in Hospitalized Patients with COVID-19
by: Min-Kyu Kang, et al.
Published: (2022-09-01)

Serial testing of healthcare workers for latent tuberculosis infection and long-term follow up for development of active tuberculosis.
by: Youngmok Park, et al.
Published: (2018-01-01)

Albumin‐myosteatosis gauge as a novel prognostic risk factor in patients with non‐metastatic colorectal cancer
by: Yerim Kim, et al.
Published: (2023-04-01)

Differences of respiratory mechanics in mechanical ventilation of acute respiratory distress syndrome between patients with COVID-19 and Influenza A
by: Eunki Chung, et al.
Published: (2024-03-01)

Treatment of Mycobacterium avium Complex Pulmonary Disease
by: Yong-Soo Kwon, M.D., et al.
Published: (2019-01-01)

Prognostic impact of the ratio of the main pulmonary artery to that of the aorta on chest computed tomography in patients with idiopathic pulmonary fibrosis
by: Ji Soo Choi, et al.
Published: (2019-04-01)

Disseminated <it>Mycobacterium avium </it>complex infection in an immunocompetent pregnant woman
by: Kim Woo, et al.
Published: (2006-10-01)

The Clinical Significance of Myosteatosis in Survival Outcomes in Patients with Hepatocellular Carcinoma Treated with Sorafenib
by: Min Kyu Kang, et al.
Published: (2024-01-01)

Treatment outcomes of Mycobacterium avium complex pulmonary disease according to disease severity
by: Bo-Guen Kim, et al.
Published: (2022-02-01)

The Impact of Myosteatosis Percentage on Short-Term Mortality in Patients with Septic Shock
by: June-sung Kim, et al.
Published: (2022-05-01)

Spontaneous Cultural Conversion Rate of <i>Mycobacterium avium</i> Complex Pulmonary Disease Based on BACES Severity
by: Bo-Guen Kim, et al.
Published: (2023-11-01)

Role of ethambutol and rifampicin in the treatment of Mycobacterium avium complex pulmonary disease
by: Hyung-Jun Kim, et al.
Published: (2019-11-01)

Experimental Reactivation of Pulmonary Mycobacterium avium Complex Infection in a Modified Cornell-Like Murine Model.
by: Seung Bin Cha, et al.
Published: (2015-01-01)

A marmoset model for Mycobacterium avium complex pulmonary disease.
by: Jay Peters, et al.
Published: (2023-01-01)

A marmoset model for Mycobacterium avium complex pulmonary disease
by: Jay Peters, et al.
Published: (2023-01-01)

Old age is associated with worse treatment outcome and frequent adverse drug reaction in Mycobacterium avium complex pulmonary disease
by: Joong-Yub Kim, et al.
Published: (2022-07-01)

Association between Dietary Patterns and Chronic Obstructive Pulmonary Disease in Korean Adults: The Korean Genome and Epidemiology Study
by: Moon-Kyung Shin, et al.
Published: (2021-12-01)

Impact of age on mortality and transfer to long-term care in patients in an intensive care unit
by: Eunki Chung, et al.
Published: (2023-12-01)

Prediction of 1-year treatment outcome using early sputum culture conversion status in Mycobacterium abscessus pulmonary disease
by: Yea Eun Park, et al.
Published: (2021-06-01)

Mycobacterium avium complex in the liver
by: Andrew P. Laramore, et al.
Published: (2009-07-01)

Exacerbation of Mycobacterium avium pulmonary infection by comorbid allergic asthma is associated with diminished mycobacterium-specific Th17 responses
by: Yeeun Bak, et al.
Published: (2021-12-01)

Alterations in lung and gut microbiota reduce diversity in patients with nontuberculous mycobacterial pulmonary disease
by: Ji Yeon Choi, et al.
Published: (2023-11-01)

Effect of multidrug therapy on the prognosis of Mycobacterium avium complex pulmonary disease
by: Atsuhito Ushiki, et al.
Published: (2024-02-01)

Mycobacterium avium complex pulmonary disease patients with limited treatment options
by: Stefano Aliberti, et al.
Published: (2024-01-01)

Longitudinal changes in radiographic features of pulmonary Mycobacterium avium complex diseases
by: Chie Watanabe, et al.
Published: (2023-08-01)

Serum oxidative stress in patients with pulmonary Mycobacterium avium complex disease
by: Hiroki Wakabayashi, et al.
Published: (2019-11-01)

Outcomes of Inhaled Amikacin and Clofazimine-Containing Regimens for Treatment of Refractory <i>Mycobacterium avium</i> Complex Pulmonary Disease
by: Bo-Guen Kim, et al.
Published: (2020-09-01)

Management of Mycobacterium avium complex and Mycobacterium abscessus pulmonary disease: therapeutic advances and emerging treatments
by: Kartik Kumar, et al.
Published: (2022-02-01)

Intracellular and in vivo activities of oxazolidinone drugs against Mycobacterium avium complex infection
by: Ju Mi Lee, et al.
Published: (2023-11-01)

Association of ISMav6 with the Pattern of Antibiotic Resistance in Korean Mycobacterium avium Clinical Isolates but No Relevance between Their Genotypes and Clinical Features.
by: Su-Young Kim, et al.
Published: (2016-01-01)

Myosteatosis and aortic calcium score on abdominal CT as prognostic markers in non-dialysis chronic kidney disease patients
by: Ahyun Kim, et al.
Published: (2024-04-01)

Comparison of Treatment Outcomes of Cavitary Mycobacterium avium Complex Pulmonary Disease with Streptomycin or Amikacin Use
by: Seong Min Kim, et al.
Published: (2023-06-01)

Impact of non-cystic fibrosis bronchiectasis on critically ill patients in Korea: a retrospective observational study
by: Youngmok Park, et al.
Published: (2021-08-01)

Prognostic impact of myosteatosis in patients with colorectal cancer: a systematic review and meta‐analysis
by: Chan Mi Lee, et al.
Published: (2020-10-01)

Rapid differentiation of Mycobacterium avium subsp. avium and Mycobacterium avium subsp. paratuberculosis by amplification of insertion element IS901
by: P. Svastova, et al.
Published: (2002-05-01)

A comparative study of <it>Mycobacterium avium </it>subsp. <it>avium </it>and <it>Mycobacterium avium </it>subsp. <it>hominissuis </it>in experimentally infected pigs
by: Agdestein Angelika, et al.
Published: (2012-01-01)

Elevated serum CA 19-9 levels in patients with pulmonary nontuberculous mycobacterial disease
by: Ji Young Hong, et al.
Published: (2016-01-01)

Effectiveness of pirfenidone in idiopathic pulmonary fibrosis according to the autoantibody status: a retrospective cohort study
by: Myung Jin Song, et al.
Published: (2021-05-01)